Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Esophagus 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2330Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1782Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 935Prednisone 925Cetuximab 921Lenalidomide 916Trastuzumab 901

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × perfluorobutane × Clear all
NCT03578224 2025-05-18

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
35 enrolled
Gastrointestinal

Esophagus

NCT02652923 2023-01-23

Contrast Ultrasound Detection of Sentinel Lymph Nodes

Thomas Jefferson University

Phase 1/2 Completed
98 enrolled
Breast

Breast Neoplasms

NCT05068076 2021-12-21

Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC

Institute of Liver and Biliary Sciences, India

Phase NA Completed
21 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡